Agree Realty Corporation
ADC | NYSE
$67.81
+$0.74 (+1.10%)
Nov 2, 2026, 1:16 PM ET · Market open
Company Profile
Agree Realty Corporation functions as a publicly traded Real Estate Investment Trust (REIT), concentrating its efforts on the acquisition and development of commercial properties. These assets are primarily net-leased to leading companies within the retail sector. As of September 30, 2020, the firm oversaw a substantial portfolio of 1,027 properties, which were distributed across 45 U.S. states and encompassed a total gross leasable area of approximately 21.0 million square feet. Shares of Agree Realty's common stock are available for trade on the New York Stock Exchange, identified by the ticker symbol ADC.
Key Executives
| Name | Position |
|---|---|
| Joel N. Agree | President, Chief Executive Officer & Director |
| Larry Kaufman | Chief Information Officer & Vice President of Continuous Improvement |
| Nicole Witteveen | Chief Operating Officer |
| Peter Coughenour | Chief Financial Officer, Secretary & Investor Relations Professional |
| Craig Erlich | Chief Growth Officer |
| Danielle Spehar | General Counsel |
| Kristina Kolbas | Vice President of People & Culture |
| Reuben Goldman Treatman | Senior Director of Corporate Finance |
| Richard A. Agree | Executive Chairman of the Board |
| Stephen Breslin | VP & Chief Accounting Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 02, 2026 | 8-K | Current Report |
| Sep 23, 2026 | 4 | Filing |
| Sep 22, 2026 | 8-K | Current Report |
| Sep 18, 2026 | 424B5 | Filing |
| Sep 17, 2026 | FWP | Filing |
| Sep 17, 2026 | FWP | Filing |
| Sep 17, 2026 | 424B5 | Filing |
| Sep 17, 2026 | 4 | Filing |
| Sep 17, 2026 | 4 | Filing |
| Sep 02, 2026 | 4 | Filing |
Agree Realty Corporation
| Country | United States |
| IPO Date | Apr 15, 1994 |
| Industry | REIT - Retail |
| Sector | Real Estate |
| Employees | 90 |
| CEO | Joel N. Agree |
Contact Details
32301 Woodward Avenue Royal Oak,
Michigan 48073 United States
Stock Details
| Ticker Symbol | ADC |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000917251 |
| CUSIP Number | 008492100 |
| ISIN Number | US0084921008 |
| SIC Code | 6798 |
Recent News
- 11 hours ago / prnewswire.comADC Therapeutics to Announce Third Quarter 2026 Financial Results on November 9, 2026
- 1 day ago / 247wallst.comThe 10-Year Treasury Yield Fell 33 Basis Points. Here Are 5 Net-Lease REITs to Watch
- 2 days ago / seekingalpha.comIf I Could Only Buy 3 REITs After The Sell-Off
- 3 days ago / 247wallst.comRealty Income and Agree Realty Both Raised Guidance. Which Dividend Looks Stronger?
- 3 days ago / globenewswire.comAkari Therapeutics to Highlight Novel RNA-Splicing ADC Payload Strategy at the 3rd Annual ADC Payload Summit
- 4 days ago / prnewswire.comADC Therapeutics Announces ZYNLONTA® Updates in Japan
- 4 days ago / seekingalpha.comUndercovered Dozen: Micron, i-80 Gold, Hercules Capital, And More
- 7 days ago / seekingalpha.comAgree Realty: Not Much Has Changed Except A Better Entry Point
- 8 days ago / seekingalpha.comREITs Rebound As Earnings Deliver
- 8 days ago / globenewswire.comArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026
Add to Watchlist
Select watchlists to add or remove ADC